Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Membrane-associated RING-CH protein (MARCH8) is a novel glycolysis repressor targeted by miR-32 in colorectal cancer

Fig. 4

HK2 inhibitor partially rescues the effect of MARCH8 knockdown in CRC. A Proliferation curve of LOVO cells treated with shMARCH8 and lonidamine; B ECAR and (C) OCR curve of LOVO cells transfected with shMARCH8 and the HK2 inhibitor lonidamine D Tumour size of LOVO cells treated with shMARCH8 and the HK2 inhibitor lonidamine; E Tumour growth curve of LOVO cells treated with shMARCH8 and the HK2 inhibitor lonidamine; F Tumour weight of LOVO cells treated with shMARCH8 and the HK2 inhibitor lonidamine; *P < 0.05, **P < 0.01, ***P < 0.001 vs. vector

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us